Reagents and Supplies

This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to Illumina, Inc., San Diego, CA 92122 on a sole source basis to procure various types of reagents and supplies specific for the existing Illumina HiSeq 2500 Sequencer instrument within the NIH Clinical Center. Illumina, Inc. is the only vendor/manufacturer that can provide the full test menu required. The proprietary next-generation sequencing (NGS) reagents and supplies provide a molecular diagnosis for patients with severe immune disorders. These reagents and supplies are therefore the only ones that can meet the needs of clinical testing conducted by Immunology Service. Department of Laboratory Medicine (DLM) will telephone or e-mail request for required reagents and supplies on a needed basis.

The estimated product list is attached to this notice and titled - Attachment 1 - List of Supplies 19-001096. The government reserves the right to increase quantities pursuant to FAR 52.217-6.

This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b)(1)(i) allowing the Contracting Officer (CO) to solicit from one source. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

The North American Industry Classification System (NAICS) code for this acquisition is 325414 with a large business standard size of 1,250 employees.

This notice of intent to award is not a request for competitive quotations. Interested concerns capable of providing the same products or services as described in this notice may submit a capability statement outlining their capabilities. No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.

Each response should include the following Business Information:
a. DUNS number and tax identification number.
b. Company Name, address, POC, Phone and Email address
c. Current GSA Schedules or NAICS codes appropriate to this Award.
d. Capability Statement

Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Barbara Taylor, taylorb@cc.nih.gov by the due date and time marked in this notice.

.